Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-20

Clinical Trial Update: A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD) [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study of GSK2894512 cream in adults with atopic dermatitis; results from the completed trial have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GSK2894512 cream (GSK2894512)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dermatitis, Atopic | Phase 2 | Status: COMPLETED | Results posted: 2017-11-20